PERNO, CARLO-FEDERICO
PERNO, CARLO-FEDERICO
Dipartimento di Medicina sperimentale e Chirurgia (attivo dal 1990 al 2018)
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing
2011-09-01 Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing
2011-09-02 Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf
1,2,3-TRIAZOLE-[2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-BETA-D-RIBOFURANOSYL]-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOL 2'',2''-DIOXIDE) (TSAO) ANALOGS - SYNTHESIS AND ANTI-HIV-1 ACTIVITY
1994-01-01 Alvarez, R; Velazquez, S; Sanfelix, A; Aquaro, S; Declercq, E; Perno, Cf; Karlsson, A; Balzarini, J; Camarasa, M
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study
2016-07-01 Nozza, S; Pignataro, Ar; Galli, L; Svicher, V; Alteri, C; Boeri, E; Ripa, M; Castagna, A; Sampaolo, M; Clementi, M; Perno, Cf; Lazzarin, A
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study
2016-07-01 Nozza, S; Pignataro, A; Galli, L; Svicher, V; Alteri, C; Boeri, E; Ripa, M; Castagna, A; Sampaolo, M; Clementi, M; Perno, Cf; Lazzarin, A
9-(2-Phosphonylmethoxyethyl)adenine increases the survival of influenza virus-infected mice by an enhancement of the immune system
1994-01-01 Villani, N; Calio', R; Balestra, E; Balzarini, J; De Clercq, E; Fabrizi, E; Perno, Cf; DEL GOBBO, V
A boceprevir failure in a patient infected with HCV-genotype 1g: importance and limitations of virus genotyping prior to HCV protease inhibitor-based therapy
2013-02-15 Cento, V; Landonio, S; De Luca, F; Di Maio, V; Micheli, V; Mirabelli, C; Niero, F; Magni, C; Rizzardini, G; Perno, Cf; CECCHERINI SILBERSTEIN, F
A case of Italian HIV-2 infection: a genetic analysis
2011-03-31 Ciccozzi, M; Babakir Mina, M; Cella, E; Bertoli, A; Lo Presti, A; Maniar, J; Perno, Cf; Ciotti, M
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection.
2015-01-01 Aragri, M; Coppola, N; Alteri, C; Battisti, A; Sagnelli, C; Pisaturo, M; Bellocchi, M; Salpini, R; Starace, M; Armenia, D; Carioti, L; Pollicita, M; Sagnelli, E; Perno, C; Svicher, V
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro
2020-02-23 Salpini, R; Piermatteo, L; Battisti, A; Colagrossi, L; Aragri, M; Yu La Rosa, K; Bertoli, A; Saccomandi, P; Lichtner, M; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Iapadre, N; Cerva, C; Aquaro, S; Angelico, M; Sarmati, L; Andreoni, M; Verheyen, J; Ceccherini-Silberstein, F; Levrero, M; Perno, Cf; Belloni, L; Svicher, V
A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication
2006-01-01 Casoli, C; Pilotti, E; Perno, Cf; Balestra, E; Polverini, E; Cassone, A; Conti, S; Magliani, W; Polonelli, L
A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity
2013-01-01 Balzarini, J; Andrei, G; Balestra, E; Huskens, D; Vanpouille, C; Introini, A; Zicari, S; Liekens, S; Snoeck, R; Holý, A; Perno, Cf; Margolis, L; Schols, D
A multicenter evaluation of the Abbott RealTime HCV Genotype II assay
2010-08-01 Ciotti, M; Marcuccilli, F; Guenci, T; Babakir Mina, M; Chiodo, F; Favarato, M; Perno, Cf
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy
2015-01-01 Pollicita, M; Alteri, C; Bellocchi, M; Armenia, D; Carioti, L; Salpini, R; Colagrossi, L; Battisti, A; Aragri, M; Fabeni, L; Mariani, R; Dalessandro, M; Ranelli, A; Paoloni, M; Parruti, G; Perno, Cf; Svicher, V
A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART.
2014-08-01 Armenia, D; Soulie, C; Di Carlo, D; Fabeni, L; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Sarmati, L; Giuliani, M; Latini, A; Boumis, E; Zaccarelli, M; Bellagamba, R; Andreoni, M; Marcelin, A; Calvez, V; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf; Santoro, M
Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: An international comparison (the GUESS Study)
2005-01-01 Zolopa, A; Lazzeroni, L; Rinehart, A; Vezinet, F; Clavel, F; Collier, A; Conway, B; Gulick, R; Holodniy, M; Perno, Cf; Shafer, R; Richman, D; Wainberg, M; Kuritzkes, D
Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems
1996-01-01 Balzarini, J; Aquaro, S; Perno, Cf; Witvrouw, M; Holy, A; De Clercq, E
Administration of fludarabine-loaded autologous red blood cells in simian immunodeficiency virus-infected sooty mangabeys depletes pSTAT-1-expressing macrophages and delays the rebound of viremia after suspension of antiretroviral therapy
2006-01-01 Cervasi, B; Paiardini, M; Serafini, S; Fraternale, A; Menotta, M; Engram, J; Lawson, B; Staprans, S; Piedimonte, G; Perno, Cf; Silvestri, G; Magnani, M
Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs
2006-01-01 Montaner, L; Crowe, S; Aquaro, S; Perno, Cf; Stevenson, M; Collman, R
Ageing with HIV: newly diagnosed older adults in Italy
2008-04-01 Orchi, N; Balzano, R; Scognamiglio, P; Navarra, A; De Carli, G; Elia, P; Grisetti, S; Sampaolesi, A; Giuliani, M; De Filippis, A; Puro, V; Ippolito, G; Girardi, E; Perno, Cf
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-set-2011 | 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing | Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf | Articolo su rivista | |
| 2-set-2011 | 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing | Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf | Articolo su rivista | |
| 1-gen-1994 | 1,2,3-TRIAZOLE-[2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-BETA-D-RIBOFURANOSYL]-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOL 2'',2''-DIOXIDE) (TSAO) ANALOGS - SYNTHESIS AND ANTI-HIV-1 ACTIVITY | Alvarez, R; Velazquez, S; Sanfelix, A; Aquaro, S; Declercq, E; Perno, Cf; Karlsson, A; Balzarini, J; Camarasa, M | Articolo su rivista | |
| 1-lug-2016 | 48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study | Nozza, S; Pignataro, Ar; Galli, L; Svicher, V; Alteri, C; Boeri, E; Ripa, M; Castagna, A; Sampaolo, M; Clementi, M; Perno, Cf; Lazzarin, A | Articolo su rivista | |
| 1-lug-2016 | 48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study | Nozza, S; Pignataro, A; Galli, L; Svicher, V; Alteri, C; Boeri, E; Ripa, M; Castagna, A; Sampaolo, M; Clementi, M; Perno, Cf; Lazzarin, A | Articolo su rivista | |
| 1-gen-1994 | 9-(2-Phosphonylmethoxyethyl)adenine increases the survival of influenza virus-infected mice by an enhancement of the immune system | Villani, N; Calio', R; Balestra, E; Balzarini, J; De Clercq, E; Fabrizi, E; Perno, Cf; DEL GOBBO, V | Articolo su rivista | |
| 15-feb-2013 | A boceprevir failure in a patient infected with HCV-genotype 1g: importance and limitations of virus genotyping prior to HCV protease inhibitor-based therapy | Cento, V; Landonio, S; De Luca, F; Di Maio, V; Micheli, V; Mirabelli, C; Niero, F; Magni, C; Rizzardini, G; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
| 31-mar-2011 | A case of Italian HIV-2 infection: a genetic analysis | Ciccozzi, M; Babakir Mina, M; Cella, E; Bertoli, A; Lo Presti, A; Maniar, J; Perno, Cf; Ciotti, M | Articolo su rivista | |
| 1-gen-2015 | A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection. | Aragri, M; Coppola, N; Alteri, C; Battisti, A; Sagnelli, C; Pisaturo, M; Bellocchi, M; Salpini, R; Starace, M; Armenia, D; Carioti, L; Pollicita, M; Sagnelli, E; Perno, C; Svicher, V | Intervento a convegno | |
| 23-feb-2020 | A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro | Salpini, R; Piermatteo, L; Battisti, A; Colagrossi, L; Aragri, M; Yu La Rosa, K; Bertoli, A; Saccomandi, P; Lichtner, M; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Iapadre, N; Cerva, C; Aquaro, S; Angelico, M; Sarmati, L; Andreoni, M; Verheyen, J; Ceccherini-Silberstein, F; Levrero, M; Perno, Cf; Belloni, L; Svicher, V | Articolo su rivista | |
| 1-gen-2006 | A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication | Casoli, C; Pilotti, E; Perno, Cf; Balestra, E; Polverini, E; Cassone, A; Conti, S; Magliani, W; Polonelli, L | Articolo su rivista | |
| 1-gen-2013 | A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity | Balzarini, J; Andrei, G; Balestra, E; Huskens, D; Vanpouille, C; Introini, A; Zicari, S; Liekens, S; Snoeck, R; Holý, A; Perno, Cf; Margolis, L; Schols, D | Articolo su rivista | |
| 1-ago-2010 | A multicenter evaluation of the Abbott RealTime HCV Genotype II assay | Ciotti, M; Marcuccilli, F; Guenci, T; Babakir Mina, M; Chiodo, F; Favarato, M; Perno, Cf | Articolo su rivista | |
| 1-gen-2015 | A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy | Pollicita, M; Alteri, C; Bellocchi, M; Armenia, D; Carioti, L; Salpini, R; Colagrossi, L; Battisti, A; Aragri, M; Fabeni, L; Mariani, R; Dalessandro, M; Ranelli, A; Paoloni, M; Parruti, G; Perno, Cf; Svicher, V | Articolo su rivista | |
| 1-ago-2014 | A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART. | Armenia, D; Soulie, C; Di Carlo, D; Fabeni, L; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Sarmati, L; Giuliani, M; Latini, A; Boumis, E; Zaccarelli, M; Bellagamba, R; Andreoni, M; Marcelin, A; Calvez, V; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf; Santoro, M | Articolo su rivista | |
| 1-gen-2005 | Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: An international comparison (the GUESS Study) | Zolopa, A; Lazzeroni, L; Rinehart, A; Vezinet, F; Clavel, F; Collier, A; Conway, B; Gulick, R; Holodniy, M; Perno, Cf; Shafer, R; Richman, D; Wainberg, M; Kuritzkes, D | Articolo su rivista | |
| 1-gen-1996 | Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems | Balzarini, J; Aquaro, S; Perno, Cf; Witvrouw, M; Holy, A; De Clercq, E | Articolo su rivista | |
| 1-gen-2006 | Administration of fludarabine-loaded autologous red blood cells in simian immunodeficiency virus-infected sooty mangabeys depletes pSTAT-1-expressing macrophages and delays the rebound of viremia after suspension of antiretroviral therapy | Cervasi, B; Paiardini, M; Serafini, S; Fraternale, A; Menotta, M; Engram, J; Lawson, B; Staprans, S; Piedimonte, G; Perno, Cf; Silvestri, G; Magnani, M | Articolo su rivista | |
| 1-gen-2006 | Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs | Montaner, L; Crowe, S; Aquaro, S; Perno, Cf; Stevenson, M; Collman, R | Articolo su rivista | |
| 1-apr-2008 | Ageing with HIV: newly diagnosed older adults in Italy | Orchi, N; Balzano, R; Scognamiglio, P; Navarra, A; De Carli, G; Elia, P; Grisetti, S; Sampaolesi, A; Giuliani, M; De Filippis, A; Puro, V; Ippolito, G; Girardi, E; Perno, Cf | Articolo su rivista |